Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Mult Scler. 2016 Dec 7;23(10):1405–1414. doi: 10.1177/1352458516680749

Table 4.

Validation Step - Linear contrast analysis comparing outcomes across 12-MSWS benchmarks

F-value for linear term p-value t-value, equal variance p-value t-value, unequal variance p-value Partial eta-squared
T25FW 39.7 <.001 6.3 <.001 4.1 <.001 0.3
TUG 47.5 <.001 6.9 <.001 4.8 <.001 0.34
6MW 64.3 <.001 8 <.001 7.7 <.001 0.41
SSST 53.4 <.001 7.3 <.001 5.3 <.001 0.37
Steps/day 45.1 <.001 6.7 <.001 7.2 <.001 0.33
Counts/day 29.5 <.001 5.4 <.001 5.5 <.001 0.24
O2 Cost 23.7 <.001 4.9 <.001 4.3 <.001 0.21
FAP score 44.7 <.001 6.8 <.001 5.2 <.001 0.36
PASAT 1.8 0.18 1.3 0.18 1.5 0.15 0.02
SDMT 13.3 <.001 3.6 <.001 3.9 <.001 0.13
LL-FDI 141.2 <.001 11.9 <.001 11 <.001 0.61
SI 67.2 <.001 8.2 <.001 7.2 <.001 0.42

Abbreviations: 12-MSWS = Multiple Sclerosis Walking Scale – 12; T25FW = Timed 25-Foot Walk; TUG = Timed Up and Go; 6MW = 6 Minute Walk; SSST = Six Spot Step Test; FAP = Functional Ambulation Performance; PASAT = Paced Auditory Serial Addition Test; SDMT = Symbol Digit Modalities Test; LL-FDI = Late Life Function and Disability Instrument; SI = Symptom Inventory.